Vedan­ta lays off CMC staffers; Kin­cell buys Imu­gene fa­cil­i­ty for $6M

Wel­come to End­points News’ man­u­fac­tur­ing briefs, where we bring you es­sen­tial news on new builds, col­lab­o­ra­tions, re­calls and more.

Vedan­ta Bio­sciences will lay off 12 …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER